MYLK and diabetes mellitus: In addition to MAPK signaling, a recent study showed that melatonin decreased aortic endothelial permeability and atherosclerosis in a mouse model of diabetes by decreasing the expression of myosin light chain kinase (MLCK), myosin phosphatase-targeting subunit phosphorylation, and myosin light-chain phosphorylation.